Cancer and inflammatory bowel disease in the elderly

Abstract : Cancer may be a complication of inflammatory bowel disease (IBD) or its treatments. In older Crohn's disease and ulcerative colitis patients, the risk of malignancy is of particular concern. IBD diagnosis at an advanced age is associated with earlier development of colitis-associated colorectal cancer. Thiopurine use in older IBD patients is tied to an increased risk of non-Hodgkin's lymphoma, nonmelanoma skin cancer, and urinary tract cancers. Additionally, older age is accompanied by multimorbidity, an increased risk of malnutrition, and decreased life expectancy, factors that complicate the management of cancer in the elderly. The optimal approach to the increased risk of malignancy in older age IBD is appropriate cancer screening and medical treatment. This may include age-specific colorectal cancer screening and limiting UV radiation exposure. With a growing number of older IBD patients, further studies are necessary to delineate the risk of cancer in this population.
Type de document :
Article dans une revue
Digestive and Liver Disease, WB Saunders, 2016, 48 (10), pp.1105-1111. 〈10.1016/j.dld.2016.05.006〉
Liste complète des métadonnées

https://hal.univ-lorraine.fr/hal-01659114
Contributeur : Ngere Ul <>
Soumis le : vendredi 8 décembre 2017 - 10:09:02
Dernière modification le : mardi 15 mai 2018 - 16:58:02

Identifiants

Collections

Citation

Sasha Taleban, Emad Elquza, Corinne Gower-Rousseau, Laurent Peyrin-Biroulet. Cancer and inflammatory bowel disease in the elderly. Digestive and Liver Disease, WB Saunders, 2016, 48 (10), pp.1105-1111. 〈10.1016/j.dld.2016.05.006〉. 〈hal-01659114〉

Partager

Métriques

Consultations de la notice

34